Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling

Journal of Theoretical Biology

Volumn 331, Issue , 2013, Pages 1-11

  Hua, Lin ^a   Zhou, Ping ^a   Li, Lin ^a   Liu, Hong ^a   Yang, Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

MiRNA miRNA network; Targets; Topological properties

Indexed keywords

MESSENGER RNA; MICRORNA;

BAYESIAN ANALYSIS; CANCER; GENE EXPRESSION; NETWORK ANALYSIS; RNA; TOPOLOGY; TUMOR;

ARTICLE; BASAL LIKE BREAST CANCER; BAYESIAN NETWORK ANALYSIS; BREAST CANCER; CANCER CLASSIFICATION; CONTROLLED STUDY; DATA EXTRACTION; GENE EXPRESSION; INTERMETHOD COMPARISON; LUMINAL A BREAST CANCER; MIRNA SIMILARITY ANALYSIS; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WEIGHTED CORRELATION NETWORK ANALYSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 84877317774     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2013.04.008     Document Type: Article

References (56)

1. Bediaga N.G., Acha-Sagredo A., Guerra I., Viguri A., Albaina C., Diaz I.R., Rezola R., Alberdi M.J., Dopazo J., Montaner D., Renobales M.d., Fernández A.F., Field J.K., Fraga M.F., Liloglou T., Pancorbo M.M.d. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res. 2010, 12:R77.
2. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.-F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavaré S., Caldas C., Miska E.A. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007, 8(10):R214.
3. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6(11):857-866.
4. Calza S., Hall P., Auer G., Bjöhle J., Klaar S., Kronenwett U., Liu E.T., Miller L., Ploner A., Smeds J., Bergh J., Pawitan Y. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. Treat. 2006, 8(4):R34.
5. Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., Karaca G., Troester M.A., Tse C.K., Edmiston S., Deming S.L., Geradts J., Cheang M.C.U., Nielsen T.O., Moorman P.G., Earp H.S., Millikan R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295(21):2492-2502.
6. Chandra V., Girijadevi R., Nair A.S., Pillai S.S., Pillai R.M. MTar: a computational microRNA target prediction architecture for human transcriptome. BMC Bioinf. 2010, 11(Suppl. 1):S2.
7. Chin S.F., Teschendorff A.E., Marioni J.C., Wang Y., Barbosa-Morais N.L., Thorne N.P., Costa J.L., Pinder S.E., Wiel M.A.v.d., Green A.R., Ellis I.O., Porter P.L., Tavaré S., Brenton J.D., Ylstra B., Caldas C. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol. 2007, 8(10):R215.
8. Cilibrasi R., Vit́anyi P.M.B. Clustering by compression. IEEE Trans. Inf. Theory 2005, 51(4):1523-1545.
9. Bockmeyer Clemens L., Christgen M., Miiller M., Fischer S., Ahrens P., Langer F., Kreipe H., Lehmann U. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res. Treat. 2011, 130:735-745.
10. Dalman M.R., Deeter A., Nimishakavi G., Duan Z.-H. Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinf. 2012, 13(Suppl. 2):S11.
11. DeNardo D.G., Brennan D.J., Rexhepaj E., Ruffell B., Shiao S.L., Madden S.F., Gallagher W.M., Wadhwani N., Keil S.D., Junaid S.A., Rugo H.S., Hwang E.S., Jirström K., West B.L., Coussens L.M. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011, 1(1):54-67.
12. Du Z., Li L., Chen C.-F., Yu P.S., Wang J.Z. G-SESAME: web tools for GO-term-based gene similarity analysis and knowledge discovery. Nucleic Acids Res. 2009, 37:W345-W349.
13. Dutta B., Pusztai L., Qi Y., André F., Lazar V., Bianchini G., Ueno N., Agarwal R., Wang B., Shiang C.Y., Hortobagyi G.N., Mills G.B., Symmans W.F., Balázsi G. A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br. J. Cancer 2012, 106:1107-1116.
14. Enerly E., Steinfeld I., Kleivi K., Leivonen S.-K., Aure M.R., Russnes H.G., Rønneberg J.A., Johnsen H., Navon R., Rødland E., Kelä R.M., Naume B., lä M.P., Kallioniemi O., Kristensen V.N., Yakhini Z., Børresen-Dale A.-L. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011, 6(2):e16915.
15. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C.D., Chan K.K., Marcucci G., Calin G.A., Huebner K., Croce C.M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104(40):15805-15810.
16. Fan C., Oh D.S., Wessels L., Weigelt B., Nuyten D.S.A., Nobel A.B., Veer L.J.v.t., Perou C.M. Concordance among gene-expression-based predictors for breast cancer. N. Engl. J. Med. 2006, 355:560-569.
17. Freeman L.C. Centrality in social networks: conceptual clarification. Social Networks 1979, 1:215-239.
18. Furey T.S. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000, 16:906-914.
19. Gelman I.H. Emerging roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis. Genes Cancer 2010, 1(11):1147-1156.
20. Grady W.M., Parkin R.K., Mitchell P.S., Lee J.H., Kim Y.-H., Tsuchiya K.D., Washington M.K., Paraskeva C., Willson J.K.V., Kaz A.M., Kroh E.M., Allen A., Fritz B.R., Markowitz S.D., Tewari M. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008, 27(27):3880-3888.
21. Gutin G., Yeo A., Zverovich A. Traveling salesman should not be greedy: domination analysis of greedy-type heuristics for the TSP. Discrete Appl. Math. 2002, 117:81-86.
22. He D., Liu Z.-P., Chen L. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics 2011, 12:592.
23. Huang W., Wang P., Liu Z., Zhang L. Identifying disease associations via genome-wide association studies. BMC Bioinf. 2009, 10(Suppl. 1):S68.
24. Iorio M.V., Ferracin M., Liu C.-G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65(16):7065-7070.
25. Jayaswal V., Lutherborrow M., Yang Y.H. Measures of association for identifying MicroRNA-mRNA pairs of biological interest. PLoS One 2012, 7(1):e29612.
26. Jeong H., Mason S.P., Barabási A.-L., Oltvai Z.N. Lethality and centrality in protein networks. Nature 2001, 411(6833):41-42.
27. John, G.H., Langley, P., 1995. Estimating continuous distributions in Bayesian classifiers. In: Proceedings of the Eleventh Conference on Uncertainty in Artificial Intelligence, Morgan Kaufmann, San Mateo, pp. 338-345.
28. Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008, 9:559.
29. Lionetti M., Biasiolo M., Agnelli L., Todoerti K., Mosca L., Fabris S., Sales G., Deliliers G.L., Bicciato S., Lombardi L., Bortoluzzi S., Neri A. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009, 114(25):e20-e26.
30. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
31. May C.D., Sphyris N., Evans K.W., Werden S.J., Guo W., Mani S.A. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011, 13:202.
32. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007, 315(5818):1576-1579.
33. McCarthy D.J., Smyth G.K. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 2009, 25(6):765-771.
34. Neil M., Fenton N., Tailor2 M. Using Bayesian networks to model expected and unexpected operational losses. Risk Anal. 2005, 25(4):1539-1548.
35. Pang H., Lin A., Holford M., Enerson B.E., Lu B., Lawton M.P., Floyd E., Zhao H. Pathway analysis using random forests classification and regression. Bioinformatics 2006, 22(16):2028-2036.
36. Patterson T.A., Lobenhofer E.K., Fulmer-Smentek S.B., Collins P.J., Chu T.-M., Bao W., Fang H., Kawasaki E.S., Hager J., Tikhonova I.R., Walker S.J., Zhang L., Hurban P., Longueville F.d., Fuscoe J.C., Tong W., Shi L., Wolfinger R.D. Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project. Nature Biotechnol. 2006, 24:1140-1150.
37. Quesne J.L., Jones J., Warren J., Dawson S.-J., Ali H.R., Bardwell H., Blows F., Pharoah P., Caldas C. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. J. Pathol. 2012, 227(3):306-314.
38. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19(3):368-375.
39. Ruffell B., Au A., Rugo H.S., Esserman L.J., Hwang E.S., Coussens L.M. Leukocyte composition of human breast cancer. Proc. Natl. Acad. Sci. USA 2012, 109(8):2796-2801.
40. Schmidt M., Hellwig B., Gehrmann M., Koelbl H., Boehm D., Cadenas C., Rahnenfuehrer J., Hengstler J.G. Prediction of late metastasis in node-negative breast cancer. J. Clin. Oncol. 2012, 30(Suppl). abstr 10551.
41. Taylor I.W., Linding R., Warde-Farley D., Liu Y., Pesquita C., Faria D., Bull S., Pawson T., Morris Q., Wrana J.L. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol. 2009, 27(2):199-204.
42. Tibiche C., Wang E. MicroRNA regulatory patterns on the human metabolic network. Open Syst. Biol. J. 2008, 1:1-8.
43. Toft D.J., Cryns V.L. Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. Mol. Endocrinol. 2011, 25:199-211.
44. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001, 98(9):5116-5121.
45. Veiga D.F.T., Dutta B., Balázsi G. Network inference and network response identification: moving genome-scale data to the next level of biological discovery. Mol. BioSyst. 2010, 6:469-480.
46. Volinia S., Calin G.A., Liu C.-G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce(*) C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103(7):2257-2261.
47. Volinia S., Galasso M., Costinean S., Tagliavini L., Gamberoni G., Drusco A., Marchesini J., Mascellani N., Sana M.E., Jarour R.A., Desponts C., Teitell M., Baffa R., Aqeilan R., Iorio M.V., Taccioli C., Garzon R., Leva G.D., Fabbri M., Catozzi M., Previati M., Ambs S., Palumbo T., Garofalo M., Veronese A., Bottoni A., Gasparini P., Harris C.C., Visone R., Pekarsky Y., Chapelle A.d.l., Bloomston M., Dillhoff M., Rassenti L.Z., Kipps T.J., Huebner K., Pichiorri F., Lenze D., Cairo S., Buendia M.-A., Pineau P., Dejean A., Zanesi N., Rossi S., Calin G.A., Liu C.-G., Palatini J., Negrini M., Vecchione A., Rosenberg A., Croce C.M. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010, 20:589-599.
48. Wang D., Wang J., Lu M., Song F., Cui Q. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 2010, 26(13):1644-1650.
49. Wasserman S., Faust K. Social Network Analysis: Methods and Applications 1994, Cambridge University Press, Cambridge, England and New York.
50. Weigman V.J., Chao H.-H., Shabalin A.A., He X., Parker J.S., Nordgard S.H., Grushko T., Huo D., Nwachukwu C., Nobel A., Kristensen V.N., Børresen-Dale A.-L., Olopade O.I., Perou C.M. Basal-like breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Res. Treat. 2012, 133:865-880.
51. Xu J., Li C.-X., Lv J.-Y., Li Y.-S., Xiao Y., Shao T.-T., Huo X., Li X., Zou Y., Han Q.-L., Li X., Wang L.-H., Ren H. Prioritizing candidate disease miRNAs by topological features in the miRNA-target dysregulated network: case study of prostate cancer. Mol. Cancer Ther. 2011, 10(10):1857-1866.
52. Yang J., Feng X., Fu Z., Yuan C., Hong Y., Shi Y., Zhang M., Liu J., Li H., Lu K., Lin J. Ultrastructural observation and gene expression profiling of schistosoma japonicum derived from two natural reservoir hosts, water buffalo and yellow cattle. PLoS One 2012, 7(10):e47660.
53. Yang X.R., Sherman M.E., Rimm D.L., Lissowska J., Brinton L.A., Peplonska B., Hewitt S.M., Anderson W.F., Szeszenia-Dabrowska N., Bardin-Mikolajczak A., Zatonski W., Cartun R., Mandich D., Rymkiewicz G., Ligaj M., Lukaszek S., Kordek R., García-Closas M. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol. Biomarkers Prev. 2007, 16:439-443.
54. Yoon S., micheli G.D. Prediction of regulatory modules comprising microRNAs and target genes. Bioinformatics 2005, 21(Suppl. 2):ii93-ii100.
55. Zhang S., Li Q., Liu J., Zhou X.J. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics 2011, 27:i401-i409.
56. Zhou X., Marian C., Makambi K.H., Kosti O., Kallakury B.V.S., Loffredo C.A., Zheng Y.-L. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One 2012, 7(6):e39011.